These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25803649)

  • 1. Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.
    Dufour N; Debarbieux L; Fromentin M; Ricard JD
    Crit Care Med; 2015 Jun; 43(6):e190-8. PubMed ID: 25803649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Proanthocyanidins on Adhesion, Growth, and Virulence of Highly Virulent Extraintestinal Pathogenic Escherichia coli Argue for Its Use to Treat Oropharyngeal Colonization and Prevent Ventilator-Associated Pneumonia.
    Margetis D; Roux D; Gaudry S; Messika J; Bouvet O; Branger C; Ponnuswamy P; Oufella HA; Dreyfuss D; Denamur E; Ricard JD
    Crit Care Med; 2015 Jun; 43(6):e170-8. PubMed ID: 25803655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time for tailored antimicrobials: adapted bacteriophages in the ICU.
    Witzenrath M
    Crit Care Med; 2015 Jun; 43(6):1346-7. PubMed ID: 25978167
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
    Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M
    Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice.
    Dufour N; Delattre R; Chevallereau A; Ricard JD; Debarbieux L
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics.
    Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC
    J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu.
    Domínguez-Herrera J; Velasco C; Docobo-Pérez F; Rodríguez-Martínez JM; López-Rojas R; Briales A; Pichardo C; Díaz-de-Alba P; Rodríguez-Baño J; Pascual A; Pachón J
    J Antimicrob Chemother; 2013 Jul; 68(7):1609-15. PubMed ID: 23493313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guiding the management of intubated patients with pneumonia and ventilator-associated events using serial catheter-directed bronchoalveolar lavage.
    Stoeppel CM; Eriksson EA; Diaz-Flores R; Coffie P; Koshy J; Kacir C; Hawkins K; Minei J; Minshall C
    J Trauma Acute Care Surg; 2014 May; 76(5):1264-9. PubMed ID: 24747458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.
    Dufour N; Clermont O; La Combe B; Messika J; Dion S; Khanna V; Denamur E; Ricard JD; Debarbieux L;
    J Antimicrob Chemother; 2016 Nov; 71(11):3072-3080. PubMed ID: 27387322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia.
    Wang Y; Mi Z; Niu W; An X; Yuan X; Liu H; Li P; Liu Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Tong Y; Bai C
    Future Microbiol; 2016 May; 11():631-41. PubMed ID: 26925593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part I: Isolation and lytic activity estimation of bacteriophages.
    Bicalho RC; Santos TM; Gilbert RO; Caixeta LS; Teixeira LM; Bicalho ML; Machado VS
    J Dairy Sci; 2010 Jan; 93(1):93-104. PubMed ID: 20059908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of Targeted Phage Rescue in a Mouse Model of Systemic
    Schneider G; Szentes N; Horváth M; Dorn Á; Cox A; Nagy G; Doffkay Z; Maróti G; Rákhely G; Kovács T
    Biomed Res Int; 2018; 2018():7569645. PubMed ID: 30105246
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.
    Galtier M; De Sordi L; Maura D; Arachchi H; Volant S; Dillies MA; Debarbieux L
    Environ Microbiol; 2016 Jul; 18(7):2237-45. PubMed ID: 26971586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory secretion analyses in the evaluation of ventilator-associated pneumonia: a survey of current practice in pediatric critical care.
    Willson DF; Kirby A; Kicker JS
    Pediatr Crit Care Med; 2014 Oct; 15(8):715-9. PubMed ID: 25068248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains.
    Messika J; Magdoud F; Clermont O; Margetis D; Gaudry S; Roux D; Branger C; Dreyfuss D; Denamur E; Ricard JD
    Intensive Care Med; 2012 Dec; 38(12):2007-16. PubMed ID: 23052953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
    Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
    Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.